In this photo provided by the University of Maryland School of Medicine, surgeons prepare for a pig heart transplant into Lawrence Faucette at the school's hospital in Baltimore, Md., in September 2023. Two days after the transplant, Faucette was cracking jokes and able to sit in a chair, doctors said Friday, Sept. 22, 2023. (Deborah Kotz/University of Maryland School of Medicine via AP)
By Lauran Neergaard
Surgeons have transplanted a pig’s heart into a dying man in a bid to prolong his life – only the second patient to ever undergo such an experimental feat. Two days later, the man was cracking jokes and able to sit in a chair, Maryland doctors said Friday.
The 58-year-old Navy veteran was facing near-certain death from heart failure but other health problems meant he wasn’t eligible for a traditional heart transplant, according to doctors at University of Maryland Medicine.
While the next few weeks will be critical, doctors were thrilled at Lawrence Faucette’s early response to the pig organ.
“You know, I just keep shaking my head – how am I talking to someone who has a pig heart?” Dr. Bartley Griffith, who performed the transplant, told The Associated Press. He said doctors are feeling “a great privilege but, you know, a lot of pressure.”
The same Maryland team last year performed the world’s first transplant of a genetically modified pig heart into another dying man, David Bennett, who survived just two months.
Faucette knew about the first case but decided the transplant was his best shot.
“Nobody knows from this point forward. At least now I have hope and I have a chance,” Faucette, from Frederick, Maryland, said in a video recorded by the hospital before the operation.
In a statement, his wife, Ann Faucette said: “We have no expectations other than hoping for more time together. That could be as simple as sitting on the front porch and having coffee together.”
There’s a huge shortage of human organs donated for transplant. Last year, there were just over 4,100 heart transplants in the U.S., a record number but the supply is so tight that only patients with the best chance of long-term survival get offered one.
Attempts at animal-to-human organ transplants have failed for decades, as people’s immune systems immediately destroyed the foreign tissue. Now scientists are trying again using pigs genetically modified to make their organs more humanlike.
Recently, scientists at other hospitals have tested pig kidneys and hearts in donated human bodies, hoping to learn enough to begin formal studies of what are called xenotransplants.
The University of Maryland attempt required special permission from the Food and Drug Administration to treat Faucette outside of a rigorous trial, because he was out of other options.
It took over 300 pages of documents filed with FDA, but the Maryland researchers made their case that they’d learned enough from their first attempt last year – even though that patient died for reasons that aren’t fully understood – that it made sense to try again.
And Faucette, who retired as a lab technician at the National Institutes of Health, had to agree that he understood the procedure’s risks.
What’s different this time: Only after last year’s transplant did scientists discover signs of a pig virus lurking inside the heart – and they now have better tests to look for hidden viruses. They also learned to avoid certain medications.
Possibly more important, while Faucette has end-stage heart failure and was out of other options, he wasn’t as near death as the prior patient.
By Friday, his new heart was functioning well without any supportive machinery, the hospital said.
“It’s just an amazing feeling to see this pig heart work in a human,” said Dr. Muhammad Mohiuddin, the Maryland team’s xenotransplantation expert. But, he cautioned, “we don’t want to predict anything. We will take every day as a victory and move forward.”
The pig heart, provided by Blacksburg, Virginia-based Revivicor, has 10 genetic modifications – knocking out some pig genes and adding some human ones to make it more acceptable to the human immune system.
Plant-based meat giant Beyond Meat's reign over the fast food world continues, as McDonald's announced that it is expanding its test of Beyond's McPlant burger, to nearly 600 restaurants, an increase from the eight that it's been testing in since November. This comes less than two weeks after Beyond Fried Chicken made its nationwide debut at KFC restaurants, the first time that plant based chicken has been widely distributed in a fast food capacity. Arun Sundaram, Senior Equity Analyst at CFRA Research explains why these latest collaborations may be proof that Beyond Meat products could slowly be becoming an unlikely staple in the fast food and chain restaurant world as consumers opt for more healthy food options.
BD Veritor is a variation of the at-home COVID test that uses a smartphone to interpret the results. The test is taken via a nose swab test strip that is then scanned by your phone’s camera with the result clearly displayed as positive or negative. James Walker, vice president of integrated diagnostics USA for BD, joined Cheddar to discuss how the test hopefully takes the "guesswork out of testing." Walker also went into what BD is doing to deal with the surging demand for at-home tests amid the omicron spread. "While we don't disclose how much we produce, we have capacity to manufacture up to 12 million rapid antigen tests per month and are delivering on our commitments to distributors and retailers," he said.
On this episode of Cheddar Innovates: Sidechef CEO breaks down how it's building a platform to make recipe shopping easy; Luum CEO explains the process of having a robot put on eyelash extensions; A look at Curiosity Stream's new original series, 'Evolve.'
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
With the 2022 Beijing Winter Olympics right around the corner, experts are warning that climate change is threatening not only the event but also the future of snow sports. Despite being the world's top polluter, China is hoping to use the event to demonstrate the country's commitment to fighting climate change, and pledging to host a "low carbon" games. Xubin Zeng, professor of hydrology and atmospheric sciences at the University of Arizona, joins Cheddar News.
New research is suggesting that giving extra cash to low-income mothers can actually influence the brain development of their infants. These findings provide the first rigorous evidence of how payments and monetary support can affect children in the early years of life. Authors of the study, Nathan Fox, professor in the department of human development at the University of Maryland, and Sonya Troller-Renfree, postdoctoral research associate at Teachers College at Columbia University, join Cheddar News to discuss.
Communities of color are disproportionately affected by climate change and continuously feel the impacts. Mark Magaña, founding president and CEO of Green Latinos joined All Hands to discuss.
